Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

698 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, double-blind, placebo-controlled trial of systemically administered interferon-alpha, -beta, or -gamma in combination with cryotherapy for the treatment of condyloma acuminatum.
Bonnez W, Oakes D, Bailey-Farchione A, Choi A, Hallahan D, Pappas P, Holloway M, Corey L, Barnum G, Dunne A, et al. Bonnez W, et al. Among authors: pappas p. J Infect Dis. 1995 May;171(5):1081-9. doi: 10.1093/infdis/171.5.1081. J Infect Dis. 1995. PMID: 7538546 Clinical Trial.
A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum.
Bonnez W, Oakes D, Bailey-Farchione A, Choi A, Hallahan D, Corey L, Barnum G, Pappas PG, Halloway M, Stoler MH, Reichman RC. Bonnez W, et al. Among authors: pappas pg. Antiviral Res. 1997 Jun;35(1):41-52. doi: 10.1016/s0166-3542(97)01037-1. Antiviral Res. 1997. PMID: 9224960 Free article. Clinical Trial.
Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial.
Vazquez J, Reboli AC, Pappas PG, Patterson TF, Reinhardt J, Chin-Hong P, Tobin E, Kett DH, Biswas P, Swanson R. Vazquez J, et al. Among authors: pappas pg. BMC Infect Dis. 2014 Feb 21;14:97. doi: 10.1186/1471-2334-14-97. BMC Infect Dis. 2014. PMID: 24559321 Free PMC article. Clinical Trial.
A Multicenter, Longitudinal Cohort Study of Cryptococcosis in Human Immunodeficiency Virus-negative People in the United States.
Marr KA, Sun Y, Spec A, Lu N, Panackal A, Bennett J, Pappas P, Ostrander D, Datta K, Zhang SX, Williamson PR; Cryptococcus Infection Network Cohort Study Working Group. Marr KA, et al. Among authors: pappas p. Clin Infect Dis. 2020 Jan 2;70(2):252-261. doi: 10.1093/cid/ciz193. Clin Infect Dis. 2020. PMID: 30855688 Free PMC article.
COVID-19-Lessons Learned and Questions Remaining.
Fang FC, Benson CA, Del Rio C, Edwards KM, Fowler VG, Fredricks DN, Limaye AP, Murray BE, Naggie S, Pappas PG, Patel R, Paterson DL, Pegues DA, Petri WA, Schooley RT. Fang FC, et al. Among authors: pappas pg. Clin Infect Dis. 2021 Jun 15;72(12):2225-2240. doi: 10.1093/cid/ciaa1654. Clin Infect Dis. 2021. PMID: 33104186 Free PMC article.
Description of Cryptococcosis Following SARS-CoV-2 Infection: A Disease Survey Through the Mycosis Study Group Education and Research Consortium (MSG-19).
Walker J, McCarty T, McGwin G, Ordaya EE, Vergidis P, Ostrosky-Zeichner L, Mammadova M, Spec A, Rauseo AM, Perfect J, Messina J, Vilchez G, McMullen R, Jones CT, Pappas PG; Mycoses Study Group Education and Research Consortium (MSGERC) Cryptococcal Registry Cohort. Walker J, et al. Among authors: pappas pg. Clin Infect Dis. 2024 Feb 17;78(2):371-377. doi: 10.1093/cid/ciad551. Clin Infect Dis. 2024. PMID: 37713207 Free PMC article.
Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.
Hajjeh RA, Conn LA, Stephens DS, Baughman W, Hamill R, Graviss E, Pappas PG, Thomas C, Reingold A, Rothrock G, Hutwagner LC, Schuchat A, Brandt ME, Pinner RW. Hajjeh RA, et al. Among authors: pappas pg. J Infect Dis. 1999 Feb;179(2):449-54. doi: 10.1086/314606. J Infect Dis. 1999. PMID: 9878030
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria.
Segal BH, Herbrecht R, Stevens DA, Ostrosky-Zeichner L, Sobel J, Viscoli C, Walsh TJ, Maertens J, Patterson TF, Perfect JR, Dupont B, Wingard JR, Calandra T, Kauffman CA, Graybill JR, Baden LR, Pappas PG, Bennett JE, Kontoyiannis DP, Cordonnier C, Viviani MA, Bille J, Almyroudis NG, Wheat LJ, Graninger W, Bow EJ, Holland SM, Kullberg BJ, Dismukes WE, De Pauw BE. Segal BH, et al. Among authors: pappas pg. Clin Infect Dis. 2008 Sep 1;47(5):674-83. doi: 10.1086/590566. Clin Infect Dis. 2008. PMID: 18637757 Free PMC article. Review.
698 results